WSJ : Sanofi Nears Deal To Buy Bioverativ For More Than $11.5 Bln

(RTTNews) - Sanofi SA (SNYNF, SNY) is nearing a deal to buy hemophilia drugmaker Bioverativ Inc. (BIVV) for more than $11.5 billion as the French drugmaker looks set to clinch a big deal while it braces for generic competition for its top-selling product, the Wall Street Journal reported citing people familiar with the matter

A deal, which......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Monday, 22 January
Share |